3Gonzalez GA, Montming MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell,1989,59:675-680.
4Collier J. Vallance P. Second messenger role for NO widens to nervous and immune systems. Trends Pharmacol Sci, 1989,10:427-431.
5Ferris CD, Huganir RL, Supattapone S, et al. Purified inositol 1,4,5triphosphate receptor mediates calcium flux in reconstituted lipid vesicles. Nature,1989,342:87-99.
6Dahm LM, Landmesser LT. The regulation of synaptogenesis during normal development and following activity blockade. J Neurosci, 1991,11:238-255.
7Rodriguez-Tebar A,Dechant G,Barde YA. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron,1990,4:487-492.
8Nudo RJ,Wise BM,Sifuentes F,et al. Neutral substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science,1996,272:1791-1794.
9Stroke Unit Trialists' Collaboration. Collaborative systematic review of the raudomized trials of organised in patient(stroke unit) case after stroke.BMJ,1997,314:1151-1159.
10Stroke Unit Trialists' Collaboration. How do stroke units improve patient outcomes?Stroke,1997,28:2139-2144.
7Guralnik JM, Ferrucci L, Balfour JL, et al. Progressive versus catastrophic loss of the ability to walk: implications for the prevention of mobility loss. J Am Geriatr Soc, 2001,49 ( 11 ) : 1463 -1470.
8Mitoma H, Hayashi R, Yanagisawa N, et al. Gait disturbances in patients with pontine medial tegmental lesions : clinical characteristics and gait analysis. Arch Neurol, 2000,57 ( 7 ) : 1048- 1057.
9Suzuki K, Yamada Y, Handa T, et al. Relationship between stride length and walking rate in gait training for hemiparetic stroke patients. Am J Phys Med Rehabil, 1999,78 (2) :147-152.
10Dever GG. Lower Limb Bracing,Orthotic Etcetera. New Haven: Elizabeth Licht, 1966:249-273.